SCHEMBL18166606

SCHEMBL18166606

COc1ccc(OC)c(CCNC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)c1

nearest known ligand 0.74

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.74
CYP3A4 P08684 1/20 0.74
LMNA P02545 1/20 0.61
ALOX15 P16050 1/20 0.59
RXFP1 Q9HBX9 10/20 0.59
TP53 P04637 2/20 0.59
MAPK1 P28482 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.54
GAA P10253 2/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP2C9 P11712 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
HTT P42858 1/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1064143 0.88 CYP1A2 (0.72) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL1065336 0.86 CYP1A2 (0.78) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL12584437 0.85 CYP1A2 (1.00) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL19036415 0.85 CYP1A2 (0.61) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL1064204 0.84 CYP1A2 (0.75) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL18166575 0.84 CYP1A2 (0.75) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL18166670 0.84 CYP1A2 (0.69) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL18166547 0.83 CYP1A2 (0.85) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL1064798 0.82 CYP1A2 (0.69) CYP1A2CYP3A4LMNAALOX15RXFP1
SCHEMBL19036645 0.80 ALOX15 (0.73) CYP1A2CYP3A4LMNAALOX15RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 EP disclosed